To the full analysis
Penumbra stock: growth
PENPenumbra reported $1.4B in revenue for fiscal 2025, up 17.5% on the prior year, up 20.2% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
25.5%
per year from 2012 to 2025, per share 21.1%
Earnings (Annual rate)
41.5%
per year from 2012 to 2025, per share 36.5%
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2012 | |
|---|---|---|---|
| Revenue | 20.2% | 22.4% | 25.5% |
| Revenue per share | 18.1% | 8.8% | 21.1% |
| Earnings | no data | 54.0% | 41.5% |
| Earnings per share | no data | 48.1% | 36.5% |
| Free cash flow | no data | no data | no data |
| Free cash flow per share | no data | no data | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2012 | $73.14M | $1.96M | $0 |
| 2013 | $88.85M | $4.1M | −$4.19M |
| 2014 | $125.51M | $2.25M | −$10.28M |
| 2015 | $186.1M | $2.37M | −$27.75M |
| 2016 | $263.32M | $14.81M | −$26.44M |
| 2017 | $333.76M | $4.66M | −$2.34M |
| 2018 | $444.94M | $6.6M | $19.21M |
| 2019 | $547.41M | $48.46M | $4.54M |
| 2020 | $560.41M | −$15.7M | −$58M |
| 2021 | $747.59M | $5.28M | −$11.68M |
| 2022 | $847.13M | −$2M | −$74.96M |
| 2023 | $1.06B | $90.95M | $82.12M |
| 2024 | $1.19B | $14.01M | $147.3M |
| 2025 | $1.4B | $177.69M | $174.93M |
Revenue by segment
How Penumbra, Inc. makes its money and how that has shifted. Names are as the company reports them.
- Peripheral Vascular59%
- Neuro41%
Figures as a table
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | Share 2022 | |
|---|---|---|---|---|---|---|---|---|
| Peripheral Vascular | $77.78M | $101.32M | $150.61M | $215.72M | $267.78M | $408.88M | $499.39M | 59% |
| Neuro | $185.53M | $232.45M | $294.33M | $331.69M | $292.63M | $338.71M | $347.74M | 41% |
| Total revenue | $263.32M | $333.76M | $444.94M | $547.41M | $560.41M | $747.59M | $847.13M | 100% |
Revenue by region
Where Penumbra, Inc. generates its revenue.
- United States$1.1B78%
- Outside the US$311.9M22%
The company split earlier years differently. A history would not be comparable, so only 2025 is shown.
Figures as a table
| 2025 | Share 2025 | |
|---|---|---|
| United States | $1.09B | 77.8% |
| Outside the US | $311.9M | 22.2% |
| Total revenue | $1.4B | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 1 Aug 2025)
- Valuation signal Overvalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.